Genetic Disease, Genotype and Protein - Clinical Research Informer

Molecular Diagnostic Tests: The Unsung Hero of Precise Clinical Decision Making

Roots Analysis

AUGUST 12, 2024

Such test can be used for gene expression profiling, genotyping and detecting chromosomal abnormalities. Protein Based Assays- These tests measure the presence and levels of specific proteins, which can serve as biomarkers for various diseases. Examples includes microarrays and fluorescence in situ hybridization.

Genetics

Genetics Gene Expression RNA DNA

FDA Approves Oxlumo (lumasiran) for the Treatment of Primary Hyperoxaluria Type 1

The Pharma Data

NOVEMBER 24, 2020

PH1 is an ultra-rare genetic disease characterized by oxalate overproduction. About Primary Hyperoxaluria Type 1 (PH1) PH1 is an ultra-rare genetic disease that affects an estimated one to three individuals per million in the United States and Europe. Oxlumo should be administered by a healthcare professional.

FDA Approval

FDA Approval Production RNA Medicine

Clinical Research Informer

Molecular Diagnostic Tests: The Unsung Hero of Precise Clinical Decision Making

FDA Approves Oxlumo (lumasiran) for the Treatment of Primary Hyperoxaluria Type 1

Webinars

Stay Connected